Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novozymes — 9M 2020 Earnings Presentation
12 slides from Novonesis A/s Class B's earnings presentation, Oct 21, 2020
Slide 1: Conference call 9M 2020
Conference call 9M 2020 October 21, 2020
Slide 2: Forward Looking Statement
Disclaimer Forward Looking Statement This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limite
Slide 3: Highlights
Latest results Highlights Satisfactory first nine months despite COVID-19 implications. Full-year 9M 2020 Q3 2020 EBIT margin and FCF outlook raised; sales outlook maintained with Realized Realized midpoint of range as most likely outcome Sales performance, organic % +1 -3 • More customer-centric or
Slide 4: Organic sales performance by geography
Latest results Organic sales performance by geography Europe, Middle East ⚫ Main sites with production and R&D ⚪ Satellite production site ⚫ Satellite R&D site North America & Africa 32% 9M y/y: -4% Q3 y/y: -4% 9M y/y: 5% Q3 y/y: -1 % 40% of sales of sales ⚫ ⚪ ⚫ ⚫ ⚫ ⚫ ⚫ ⚪ ⚪ ⚫ Latin America Asia Paci
Slide 5: Household Care
Latest results Household Care Strong sales performance; Q3 impacted by destocking YTD organic sales performance (y/y) • Organic sales; 9M y/y: +7% (Q3 y/y: -1%) • Strong sales performance driven by rollout of the freshness technology and increased enzymatic penetration 7% • Sales amplified by COVID-
Slide 6: Food & Beverages
Latest results Food & Beverages Solid first nine months led by baking YTD organic sales performance (y/y) • Organic sales; 9M y/y: +5% (Q3 y/y: +1%) • Growth led by baking, beverages declined from lower 9% demand in brewing 4% 5% • Q3 impacted by destocking as expected, especially in baking 1% • Q3
Slide 7: Bioenergy
Latest results Bioenergy Improvement in Q3, though still below last year YTD organic sales performance (y/y) • Organic sales; 9M y/y: -11% (Q3 y/y: -5%) • U.S. ethanol production impacted by COVID-19 restrictions; 14% 10% less decline in Q3 • Sales outside the U.S. growing, also in Q3 -4% -7% • Intr
Slide 8: Agriculture & Feed
Latest results Agriculture & Feed Growth driven by Agriculture; Q3 significantly impacted by YTD organic sales performance (y/y) inventory adjustments in Feed • Organic sales; 9M y/y: +4% (Q3 y/y: -19%) • Agriculture performed well in upstream corn inoculants but weaker in downstream solutions; Q3 n
Slide 9: Financials – Performance 9M
Latest results Financials – Performance 9M Solid financial performance despite challenging conditions • Organic sales; 9M y/y: +1%; DKK sales -1% • Gross margin at 56.2% — benefiting from productivity improvements, lower input costs and one-offs • EBIT margin at 27.0% — roughly 1 %-point improvement
Slide 10: Financials – Outlook 2020
Latest results Financials – Outlook 2020 2020 outlook; • Organic sales performance of -2% to +2%, midpoint of range as most likely outcome • Household Care and Food & Beverages maintained at mid-single digit growth • Bioenergy and Technical & Pharma expected to decline double-digit • Agriculture & F
Slide 11: Summary
Latest results Summary Satisfactory performance considering COVID-19 implications • 2020 outlook for sales at -2% to +2%; increasingly gaining confidence that the midpoint of the range is the most likely outcome • Increased outlook for EBIT margin and FCF before acquisitions • New more customer-cent
Slide 12: Rethink Tomorrow